Cargando…
Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls
Metabolites of the kynurenine pathway of tryptophan degradation, in particular, the N-Methyl-d-aspartic acid receptor antagonist kynurenic acid (KYNA), are increasingly recognized as primary pathophysiological promoters in several psychiatric diseases. Studies analyzing central KYNA levels from subj...
Autores principales: | Sellgren, Carl M., Gracias, Jessica, Jungholm, Oscar, Perlis, Roy H., Engberg, Göran, Schwieler, Lilly, Landen, Mikael, Erhardt, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351610/ https://www.ncbi.nlm.nih.gov/pubmed/30696814 http://dx.doi.org/10.1038/s41398-019-0378-9 |
Ejemplares similares
-
Chronic Antipsychotic Treatment in the Rat – Effects on Brain Interleukin-8 and Kynurenic Acid
por: Larsson, Markus K, et al.
Publicado: (2015) -
Twin study shows association between monocyte chemoattractant protein-1 and kynurenic acid in cerebrospinal fluid
por: Johansson, Viktoria, et al.
Publicado: (2019) -
Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients
por: Schwieler, Lilly, et al.
Publicado: (2016) -
Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in
Reference Memory in Mice
por: Peyton, Lee, et al.
Publicado: (2019) -
Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria
por: Holmberg, Dag, et al.
Publicado: (2017)